The vast majority of head lice in the United States are now resistant to most over-the-counter treatments, meaning that it’s now especially difficult to vanquish the tiny blood-sucking parasites, a new study finds.
Researchers found that head lice (Pediculus humanus capitis) in 42 of the 48 states studied carry an average of three genetic mutations that make these bugs impervious to popular over-the-counter anti-lice remedies. In the remaining six states, the lice had zero, one or two of the three mutations, on average, the researchers reported in the study, published online March 31 in the Journal of Medical Entomology.
Moreover, a detailed analysis showed that 98.3 percent of the genes involved in these mutations were, in fact, mutated in a way that helped the lice survive the most popular treatments, the researchers found.
“What it’s telling us is that, right now, these over-the-counter products aren’t nearly as effective as they used to be,” said study principal investigator John Clark, a professor of environmental toxicology and chemistry at the University of Massachusetts Amherst.
Clark, who studies the effects of insecticides on the brain, started researching lice after hearing that people were having trouble getting rid of the insects. He and his colleagues reached out to school nurses across the country, and asked them to collect samples of head lice that could be used for the study.
In all, the researchers got samples from 138 sites within 48 states (Alaska and West Virginia were not included). In most states, the samples came from urban, suburban and rural schools, which helped the researchers understand how much lice resistance had spread, Clark said.
Lice are insects, and in the past, over-the-counter insecticides killed lice by causing louse muscle paralysis and death. But now,….